{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:22:57Z","timestamp":1790256177167,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K23DA044324-01"],"award-info":[{"award-number":["K23DA044324-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DA048169"],"award-info":[{"award-number":["K23DA048169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021045","name":"Massachusetts Department of Public Health","doi-asserted-by":"crossref","award":["163274"],"award-info":[{"award-number":["163274"]}],"id":[{"id":"10.13039\/100021045","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049412"],"award-info":[{"award-number":["UM1DA049412"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049412"],"award-info":[{"award-number":["UM1DA049412"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["UM1DA049412"],"award-info":[{"award-number":["UM1DA049412"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11606-021-06904-4","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T14:05:59Z","timestamp":1624370759000},"page":"3810-3819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-0796","authenticated-orcid":false,"given":"Jessica L.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davida","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"1","key":"6904_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","volume":"38","author":"R Mojtabai","year":"2019","unstructured":"Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M. Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities. Health Affairs. 2019;38(1):14-23. doi:https:\/\/doi.org\/10.1377\/hlthaff.2018.05162","journal-title":"Health Affairs."},{"issue":"4","key":"6904_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMsr1706626","volume":"377","author":"ND Volkow","year":"2017","unstructured":"Volkow ND, Collins FS. The Role of Science in Addressing the Opioid Crisis. N Engl J Med. 2017;377(4):391-394. doi:https:\/\/doi.org\/10.1056\/NEJMsr1706626","journal-title":"N Engl J Med."},{"issue":"3","key":"6904_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, et al. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. Ann Intern Med. 2018;169(3):137-145. doi:https:\/\/doi.org\/10.7326\/M17-3107","journal-title":"Ann Intern Med."},{"issue":"1","key":"6904_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/add.12333","volume":"109","author":"Y-I Hser","year":"2014","unstructured":"Hser Y-I, Saxon AJ, Huang D, et al. Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial. Addiction. 2014;109(1):79-87. doi:https:\/\/doi.org\/10.1111\/add.12333","journal-title":"Addiction."},{"issue":"12","key":"6904_CR5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","volume":"174","author":"DA Fiellin","year":"2014","unstructured":"Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O\u2019Connor PG. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(12):1947-1954. doi:https:\/\/doi.org\/10.1001\/jamainternmed.2014.5302","journal-title":"JAMA Intern Med."},{"key":"6904_CR6","doi-asserted-by":"publisher","unstructured":"Wilson N Drug and Opioid-Involved Overdose Deaths \u2014 United States, 2017\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69. doi:https:\/\/doi.org\/10.15585\/mmwr.mm6911a4","DOI":"10.15585\/mmwr.mm6911a4"},{"key":"6904_CR7","doi-asserted-by":"publisher","unstructured":"Alpren C, Dawson EL, John B, et al. Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs\u2014Massachusetts, 2015\u20132018. Am J Public Health. Published online November 14, 2019:e1-e8. doi:https:\/\/doi.org\/10.2105\/AJPH.2019.305366","DOI":"10.2105\/AJPH.2019.305366"},{"issue":"3","key":"6904_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, et al. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. N Engl J Med. 2016;375(3):229-239. doi:https:\/\/doi.org\/10.1056\/NEJMoa1515195","journal-title":"N Engl J Med."},{"issue":"15","key":"6904_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.15585\/mmwr.mm6815a2","volume":"68","author":"MR Golden","year":"2019","unstructured":"Golden MR, Lechtenberg R, Glick SN, et al. Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs - Seattle, Washington, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(15):344-349. doi:https:\/\/doi.org\/10.15585\/mmwr.mm6815a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"6904_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.15585\/mmwr.mm6818a2","volume":"68","author":"MA Foster","year":"2019","unstructured":"Foster MA, Hofmeister MG, Kupronis BA, et al. Increase in Hepatitis A Virus Infections - United States, 2013-2018. MMWR Morb Mortal Wkly Rep. 2019;68(18):413-415. doi:https:\/\/doi.org\/10.15585\/mmwr.mm6818a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"24","key":"6904_CR11","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/j.vaccine.2015.04.019","volume":"33","author":"MG Collier","year":"2015","unstructured":"Collier MG, Drobeniuc J, Cuevas-Mota J, Garfein RS, Kamili S, Teshale EH. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection. Vaccine. 2015;33(24):2808-2812. doi:https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.019","journal-title":"Vaccine."},{"key":"6904_CR12","unstructured":"Centers for Disease Control and Prevention. Viral Hepatitis Surveillance \u2013 United States, 2018.; 2020. Accessed November 5, 2020. https:\/\/www.cdc.gov\/hepatitis\/statistics\/SurveillanceRpts.htm"},{"issue":"1","key":"6904_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","volume":"14","author":"M Hawk","year":"2017","unstructured":"Hawk M, Coulter RWS, Egan JE, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70. doi:https:\/\/doi.org\/10.1186\/s12954-017-0196-4","journal-title":"Harm Reduct J."},{"key":"6904_CR14","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174. doi:https:\/\/doi.org\/10.1136\/bmj.f174","journal-title":"BMJ."},{"issue":"1","key":"6904_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/dyt243","volume":"43","author":"EJ Aspinall","year":"2014","unstructured":"Aspinall EJ, Nambiar D, Goldberg DJ, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235-248. doi:https:\/\/doi.org\/10.1093\/ije\/dyt243","journal-title":"Int J Epidemiol."},{"issue":"1","key":"6904_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","volume":"25","author":"GJ MacArthur","year":"2014","unstructured":"MacArthur GJ, van Velzen E, Palmateer N, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34-52. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2013.07.001","journal-title":"Int J Drug Policy."},{"issue":"10","key":"6904_CR17","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S2352-3018(15)00129-0","volume":"2","author":"K Ahamad","year":"2015","unstructured":"Ahamad K, Hayashi K, Nguyen P, et al. Low Threshold Methadone Protects against HIV Incidence in a Canadian Setting: An Observational Cohort Study. Lancet HIV. 2015;2(10):e445-e450. doi:https:\/\/doi.org\/10.1016\/S2352-3018(15)00129-0","journal-title":"Lancet HIV."},{"issue":"4","key":"6904_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/00952990.2013.798662","volume":"39","author":"R Seewald","year":"2013","unstructured":"Seewald R, Bruce RD, Elam R, et al. Effectiveness and feasibility study of routine HIV rapid testing in an urban methadone maintenance treatment program. Am J Drug Alcohol Abuse. 2013;39(4):247-251. doi:https:\/\/doi.org\/10.3109\/00952990.2013.798662","journal-title":"Am J Drug Alcohol Abuse."},{"issue":"7","key":"6904_CR19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s10461-010-9812-y","volume":"15","author":"MR Charania","year":"2011","unstructured":"Charania MR, Crepaz N, Guenther-Gray C, et al. Efficacy of structural-level condom distribution interventions: a meta-analysis of U.S. and international studies, 1998-2007. AIDS Behav. 2011;15(7):1283-1297. doi:https:\/\/doi.org\/10.1007\/s10461-010-9812-y","journal-title":"AIDS Behav."},{"issue":"2","key":"6904_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/08897077.2014.989352","volume":"36","author":"SM Bagley","year":"2015","unstructured":"Bagley SM, Peterson J, Cheng DM, et al. Overdose Education and Naloxone Rescue Kits for Family Members of Opioid Users: Characteristics, Motivations and Naloxone Use. Subst Abus. 2015;36(2):149-154. doi:https:\/\/doi.org\/10.1080\/08897077.2014.989352","journal-title":"Subst Abus"},{"key":"6904_CR21","doi-asserted-by":"publisher","first-page":"102536","DOI":"10.1016\/j.drugpo.2019.07.031","volume":"75","author":"T Townsend","year":"2020","unstructured":"Townsend T, Blostein F, Doan T, Madson-Olson S, Galecki P, Hutton DW. Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. Int J Drug Policy. 2020;75:102536. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2019.07.031","journal-title":"Int J Drug Policy."},{"issue":"3","key":"6904_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/add.13668","volume":"112","author":"MKB Parmar","year":"2017","unstructured":"Parmar MKB, Strang J, Choo L, Meade AM, Bird SM. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths. Addiction. 2017;112(3):502-515. doi:https:\/\/doi.org\/10.1111\/add.13668","journal-title":"Addiction."},{"issue":"8","key":"6904_CR23","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.2105\/AJPH.2014.302062","volume":"104","author":"CS Davis","year":"2014","unstructured":"Davis CS, Ruiz S, Glynn P, Picariello G, Walley AY. Expanded Access to Naloxone Among Firefighters, Police Officers, and Emergency Medical Technicians in Massachusetts. Am J Public Health. 2014;104(8):e7-e9. doi:https:\/\/doi.org\/10.2105\/AJPH.2014.302062","journal-title":"Am J Public Health."},{"issue":"6","key":"6904_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2105\/AJPH.2020.305620","volume":"110","author":"TC Green","year":"2020","unstructured":"Green TC, Davis C, Xuan Z, Walley AY, Bratberg J. Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018. Am J Public Health. 2020;110(6):881-887. doi:https:\/\/doi.org\/10.2105\/AJPH.2020.305620","journal-title":"Am J Public Health."},{"key":"6904_CR25","unstructured":"PDAPS - Naloxone Overdose Prevention Laws. . http:\/\/www.pdaps.org\/datasets\/laws-regulating-administration-of-naloxone-1501695139"},{"issue":"4","key":"6904_CR26","doi-asserted-by":"publisher","first-page":"e202361","DOI":"10.1001\/jamanetworkopen.2020.2361","volume":"3","author":"ME Tori","year":"2020","unstructured":"Tori ME, Larochelle MR, Naimi TS. Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017. JAMA Netw Open. 2020;3(4):e202361. doi:https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2361","journal-title":"JAMA Netw Open."},{"key":"6904_CR27","unstructured":"Never Use Alone. Meeting people where they are, on the other end of the line, one human connection at a time. Accessed November 16, 2020. http:\/\/neverusealone.com\/"},{"key":"6904_CR28","unstructured":"Boston Public Health Commission. Access, Harm Reduction, Overdose Prevention, and Education (AHOPE) Program Participant Guide. Accessed September 17, 2020 https:\/\/www.bphc.org\/whatwedo\/Recovery-Services\/services-for-active-users\/Documents\/Client%20Manual%20FINAL.pdf"},{"key":"6904_CR29","doi-asserted-by":"publisher","first-page":"100474","DOI":"10.1016\/j.eclinm.2020.100474","volume":"25","author":"DG Schwartz","year":"2020","unstructured":"Schwartz DG, Ataiants J, Roth A, et al. Layperson reversal of opioid overdose supported by smartphone alert: A prospective observational cohort study. EClinicalMedicine. 2020;25:100474. doi:https:\/\/doi.org\/10.1016\/j.eclinm.2020.100474","journal-title":"EClinicalMedicine."},{"key":"6904_CR30","doi-asserted-by":"publisher","first-page":"102973","DOI":"10.1016\/j.drugpo.2020.102973","volume":"86","author":"GA Victor","year":"2020","unstructured":"Victor GA, Strickland JC, Kheibari AZ, Flaherty C. A mixed-methods approach to understanding overdose risk-management strategies among a nationwide convenience sample. Int J Drug Policy. 2020;86:102973. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2020.102973","journal-title":"Int J Drug Policy."},{"issue":"1","key":"6904_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0252-8","volume":"15","author":"M Karamouzian","year":"2018","unstructured":"Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver Canada, Harm Reduct J. 2018;15(1):1-8. doi:https:\/\/doi.org\/10.1186\/s12954-018-0252-8","journal-title":"Harm Reduct J."},{"issue":"1","key":"6904_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","volume":"16","author":"JE Goldman","year":"2019","unstructured":"Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BDL. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduction Journal. 2019;16(1):3. doi:https:\/\/doi.org\/10.1186\/s12954-018-0276-0","journal-title":"Harm Reduction Journal."},{"key":"6904_CR33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","volume":"63","author":"NC Peiper","year":"2019","unstructured":"Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. International Journal of Drug Policy. 2019;63:122-128. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2018.08.007","journal-title":"International Journal of Drug Policy."},{"key":"6904_CR34","unstructured":"Peterborough Drug Strategy. Developing an Opioid Overdose REsponse Protocol: Information for Workplaces.; 2018."},{"issue":"1","key":"6904_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13722-016-0068-3","volume":"12","author":"T Kerensky","year":"2017","unstructured":"Kerensky T, Walley AY. Opioid overdose prevention and naloxone rescue kits: what we know and what we don\u2019t know. Addict Sci Clin Pract. 2017;12(1):4. doi:https:\/\/doi.org\/10.1186\/s13722-016-0068-3","journal-title":"Addict Sci Clin Pract."},{"issue":"4","key":"6904_CR36","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/08897077.2019.1640834","volume":"41","author":"L Fozouni","year":"2020","unstructured":"Fozouni L, Buchheit B, Walley AY, Testa M, Chatterjee A. Public restrooms and the opioid epidemic. Subst Abus. 2020;41(4):432-436. doi:https:\/\/doi.org\/10.1080\/08897077.2019.1640834","journal-title":"Subst Abus."},{"issue":"24","key":"6904_CR37","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1001\/jama.2019.7998","volume":"321","author":"JM Gaeta","year":"2019","unstructured":"Gaeta JM. A Pitiful Sanctuary. JAMA. 2019;321(24):2407-2408. doi:https:\/\/doi.org\/10.1001\/jama.2019.7998","journal-title":"JAMA."},{"key":"6904_CR38","doi-asserted-by":"publisher","first-page":"103038","DOI":"10.1016\/j.drugpo.2020.103038","volume":"88","author":"BM Buchheit","year":"2020","unstructured":"Buchheit BM, Crable EL, Lipson SK, Drainoni M-L, Walley AY. \u201cOpening the door to somebody who has a chance.\u201d - The experiences and perceptions of public safety personnel towards a public restroom overdose prevention alarm system. Int J Drug Policy. 2020;88:103038. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2020.103038","journal-title":"Int J Drug Policy."},{"issue":"25","key":"6904_CR39","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMc1610047","volume":"375","author":"SC Sigmon","year":"2016","unstructured":"Sigmon SC, Ochalek TA, Meyer AC, et al. Interim Buprenorphine vs. Waiting List for Opioid Dependence. N Engl J Med. 2016;375(25):2504-2505. doi:https:\/\/doi.org\/10.1056\/NEJMc1610047","journal-title":"N Engl J Med."},{"issue":"1","key":"6904_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13722-017-0072-2","volume":"12","author":"EP Bhatraju","year":"2017","unstructured":"Bhatraju EP, Grossman E, Tofighi B, et al. Public sector low threshold office-based buprenorphine treatment: outcomes at year 7. Addiction Science & Clinical Practice. 2017;12(1):7. doi:https:\/\/doi.org\/10.1186\/s13722-017-0072-2","journal-title":"Addiction Science & Clinical Practice."},{"key":"6904_CR41","unstructured":"DiPietro B, Zur J, Tolbert J. Addressing the Opioid Crisis: Medication-Assisted Treatment at Health Care for the Homeless Programs - Issue Brief. The Henry Kaiser Family Foundation; 2019. https:\/\/www.kff.org\/report-section\/addressing-the-opioid-crisis-medication-assisted-treatment-at-health-care-for-the-homeless-programs-issue-brief\/"},{"key":"6904_CR42","doi-asserted-by":"publisher","unstructured":"Jakubowski A, Fox A. Defining Low-threshold Buprenorphine Treatment: Journal of Addiction Medicine. Published online September 2019:1. doi:https:\/\/doi.org\/10.1097\/ADM.0000000000000555","DOI":"10.1097\/ADM.0000000000000555"},{"key":"6904_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2019.09.003","volume":"107","author":"RL Snow","year":"2019","unstructured":"Snow RL, Simon RE, Jack HE, Oller D, Kehoe L, Wakeman SE. Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic. J Subst Abuse Treat. 2019;107:1-7. doi:https:\/\/doi.org\/10.1016\/j.jsat.2019.09.003","journal-title":"J Subst Abuse Treat."},{"issue":"2","key":"6904_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11606-006-0023-1","volume":"22","author":"DP Alford","year":"2007","unstructured":"Alford DP, LaBelle CT, Richardson JM, et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med. 2007;22(2):171-176. doi:https:\/\/doi.org\/10.1007\/s11606-006-0023-1","journal-title":"J Gen Intern Med."},{"key":"6904_CR45","doi-asserted-by":"publisher","unstructured":"Harris M, Johnson S, Mackin S, Saitz R, Walley AY, Taylor JL. Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report. Journal of Addiction Medicine. 2020;Publish Ahead of Print. doi:https:\/\/doi.org\/10.1097\/ADM.0000000000000682","DOI":"10.1097\/ADM.0000000000000682"},{"issue":"9","key":"6904_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.7326\/M18-1652","volume":"169","author":"SA Martin","year":"2018","unstructured":"Martin SA, Chiodo LM, Bosse JD, Wilson A. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Ann Intern Med. 2018;169(9):628-635. doi:https:\/\/doi.org\/10.7326\/M18-1652","journal-title":"Ann Intern Med."},{"key":"6904_CR47","unstructured":"OBAT Clinical Tools and Forms. Boston Medical Center Office-Based Addiction Treatment Program (OBAT). . https:\/\/www.bmcobat.org\/resources\/?category=4"},{"key":"6904_CR48","unstructured":"GetWaivered. Buprenorphine Home Induction Instructions for Patients: MGH. Get Waivered. Published July 7, 2019. Accessed December 4, 2020. https:\/\/getwaivered.com\/buprenorphine-home-induction-instructions-for-patients-mgh\/"},{"issue":"3","key":"6904_CR49","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.1503\/cmaj.74018","volume":"192","author":"PA Randhawa","year":"2020","unstructured":"Randhawa PA, Brar R, Nolan S. Buprenorphine-naloxone \u201cmicrodosing\u201d: an alternative induction approach for the treatment of opioid use disorder in the wake of North America\u2019s increasingly potent illicit drug market. CMAJ. 2020;192(3):E73. doi:https:\/\/doi.org\/10.1503\/cmaj.74018","journal-title":"CMAJ."},{"issue":"3","key":"6904_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jemermed.2019.12.034","volume":"58","author":"RJ Strayer","year":"2020","unstructured":"Strayer RJ, Hawk K, Hayes BD, et al. Management of Opioid Use Disorder in the Emergency Department: A White Paper Prepared for the American Academy of Emergency Medicine. The Journal of Emergency Medicine. 2020;58(3):522-546. doi:https:\/\/doi.org\/10.1016\/j.jemermed.2019.12.034","journal-title":"The Journal of Emergency Medicine."},{"key":"6904_CR51","doi-asserted-by":"crossref","unstructured":"Ghosh SM, Klaire S, Tanguay R, Manek M, Azar P. A Review of Novel Methods To Support The Transition From Methadone and Other Full Agonist Opioids To Buprenorphine\/Naloxone Sublingual In Both Community and Acute Care Settings. Canadian Journal of Addiction. 2019;10(4). https:\/\/journals.lww.com\/cja\/Fulltext\/2019\/12000\/A_Review_of_Novel_Methods_To_Support_The.7.aspx","DOI":"10.1097\/CXA.0000000000000072"},{"key":"6904_CR52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/SAR.S109919","volume":"7","author":"R H\u00e4mmig","year":"2016","unstructured":"H\u00e4mmig R, Kemter A, Strasser J, et al. Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method. Subst Abuse Rehabil. 2016;7:99-105. doi:https:\/\/doi.org\/10.2147\/SAR.S109919","journal-title":"Subst Abuse Rehabil."},{"issue":"4","key":"6904_CR53","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/ajad.12869","volume":"28","author":"S Klaire","year":"2019","unstructured":"Klaire S, Zivanovic R, Barbic SP, Sandhu R, Mathew N, Azar P. Rapid micro-induction of buprenorphine\/naloxone for opioid use disorder in an inpatient setting: A case series. Am J Addict. 2019;28(4):262-265. doi:https:\/\/doi.org\/10.1111\/ajad.12869","journal-title":"Am J Addict."},{"issue":"9","key":"6904_CR54","first-page":"589","volume":"88","author":"HL Muncie","year":"2013","unstructured":"Muncie HL, Yasinian Y, Oge\u2019 L. Outpatient management of alcohol withdrawal syndrome. Am Fam Physician. 2013;88(9):589-595.","journal-title":"Am Fam Physician."},{"issue":"3","key":"6904_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/JCP.0b013e3181dcb2f3","volume":"30","author":"AE Nardi","year":"2010","unstructured":"Nardi AE, Freire RC, Valen\u00e7a AM, et al. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment. J Clin Psychopharmacol. 2010;30(3):290-293. doi:https:\/\/doi.org\/10.1097\/JCP.0b013e3181dcb2f3","journal-title":"J Clin Psychopharmacol."},{"issue":"1","key":"6904_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/ADM.0000000000000691","volume":"15","author":"R Sherrick","year":"2021","unstructured":"Sherrick R. Diversion of Buprenorphine in Low-threshold Treatment. Journal of Addiction Medicine. 2021;15(1):88. doi:https:\/\/doi.org\/10.1097\/ADM.0000000000000691","journal-title":"Journal of Addiction Medicine."},{"issue":"12","key":"6904_CR57","doi-asserted-by":"publisher","first-page":"e1002715","DOI":"10.1371\/journal.pmed.1002715","volume":"15","author":"F De Crescenzo","year":"2018","unstructured":"De Crescenzo F, Ciabattini M, D\u2019Al\u00f2 GL, et al. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis. PLoS Med. 2018;15(12):e1002715. doi:https:\/\/doi.org\/10.1371\/journal.pmed.1002715","journal-title":"PLoS Med."},{"issue":"3","key":"6904_CR58","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jamapsychiatry.2019.3655","volume":"77","author":"PO Coffin","year":"2020","unstructured":"Coffin PO, Santos G-M, Hern J, et al. Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial. JAMA Psychiatry. 2020;77(3):246-255. doi:https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.3655","journal-title":"JAMA Psychiatry."},{"issue":"2","key":"6904_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/ajad.12858","volume":"28","author":"D Blevins","year":"2019","unstructured":"Blevins D, Wang X-Q, Sharma S, Ait-Daoud N. Impulsiveness as a predictor of topiramate response for cocaine use disorder. Am J Addict. 2019;28(2):71-76. doi:https:\/\/doi.org\/10.1111\/ajad.12858","journal-title":"Am J Addict."},{"key":"6904_CR60","unstructured":"Liebschutz JM, Lasser KE, Shanahan CW. Performing Urine Drug Tests. MyTOPCARE. Accessed December 3, 2020. http:\/\/mytopcare.org\/prescribers\/about-urine-drug-tests\/"},{"key":"6904_CR61","unstructured":"SCOPE of Pain (Safer\/Competent Opioid Prescribing Education) | Continuing Medical Education | School of Medicine | Boston University. Accessed August 6, 2020. https:\/\/www.scopeofpain.org\/"},{"key":"6904_CR62","doi-asserted-by":"publisher","first-page":"108147","DOI":"10.1016\/j.drugalcdep.2020.108147","volume":"214","author":"AS Huhn","year":"2020","unstructured":"Huhn AS, Hobelmann JG, Oyler GA, Strain EC. Protracted renal clearance of fentanyl in persons with opioid use disorder. Drug Alcohol Depend. 2020;214:108147. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108147","journal-title":"Drug Alcohol Depend."},{"issue":"13","key":"6904_CR63","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/archinternmed.2010.140","volume":"170","author":"PC Smith","year":"2010","unstructured":"Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155-1160. doi:https:\/\/doi.org\/10.1001\/archinternmed.2010.140","journal-title":"Arch Intern Med."},{"issue":"7","key":"6904_CR64","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11606-009-0928-6","volume":"24","author":"PC Smith","year":"2009","unstructured":"Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24(7):783-788. doi:https:\/\/doi.org\/10.1007\/s11606-009-0928-6","journal-title":"J Gen Intern Med."},{"key":"6904_CR65","doi-asserted-by":"publisher","unstructured":"Mayfield JJ, Ball EM, Tillery KA, et al. Beyond Men, Women, or Both: A Comprehensive, LGBTQ-Inclusive, Implicit-Bias-Aware, Standardized-Patient-Based Sexual History Taking Curriculum. MedEdPORTAL. 13. doi:https:\/\/doi.org\/10.15766\/mep_2374-8265.10634","DOI":"10.15766\/mep_2374-8265.10634"},{"issue":"1","key":"6904_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/jwh.2014.4866","volume":"24","author":"TL Weaver","year":"2015","unstructured":"Weaver TL, Gilbert L, El-Bassel N, Resnick HS, Noursi S. Identifying and intervening with substance-using women exposed to intimate partner violence: phenomenology, comorbidities, and integrated approaches within primary care and other agency settings. J Womens Health (Larchmt). 2015;24(1):51-56. doi:https:\/\/doi.org\/10.1089\/jwh.2014.4866","journal-title":"J Womens Health (Larchmt)."},{"issue":"9","key":"6904_CR67","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/journalofethics.2017.19.9.ecas2-1709","volume":"19","author":"K Sue","year":"2017","unstructured":"Sue K. How to Talk with Patients about Incarceration and Health. AMA J Ethics. 2017;19(9):885-893. doi:https:\/\/doi.org\/10.1001\/journalofethics.2017.19.9.ecas2-1709","journal-title":"AMA J Ethics."},{"key":"6904_CR68","unstructured":"Giftos, Jon. Returning from incarceration: reducing risks of reentry for justice-involved patietns with opioid use disorder. Presented at the: The New England Office Based Addiction Treatmetn Extension for Community Health Outcomes Tele-Education Series; March 20, 2019; Boston Medical Center, Boston, MA."},{"key":"6904_CR69","unstructured":"Centers for Disease Control and Prevention. Integrated Prevention Services for HIV Infection, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis for Persons Who Use Drugs Illicitly: Summary Guidance from CDC and the U.S. Department of Health and Human Services. MMWR. Published online 2012. Accessed August 5, 2020. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6105a1.htm"},{"issue":"3","key":"6904_CR70","doi-asserted-by":"publisher","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","volume":"3","author":"AG Wurcel","year":"2016","unstructured":"Wurcel AG, Anderson JE, Chui KKH, et al. Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs. Open Forum Infect Dis. 2016;3(3):ofw157. doi:https:\/\/doi.org\/10.1093\/ofid\/ofw157","journal-title":"Open Forum Infect Dis"},{"key":"6904_CR71","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR. 2015;64(RR-03):1-137."},{"issue":"2","key":"6904_CR72","first-page":"109","volume":"99","author":"AJ Visconti","year":"2019","unstructured":"Visconti AJ, Sell J, Greenblatt AD. Primary Care for Persons Who Inject Drugs. Am Fam Physician. 2019;99(2):109-116.","journal-title":"Am Fam Physician."},{"key":"6904_CR73","doi-asserted-by":"publisher","unstructured":"Rosenthal ES, Silk R, Mathur P, et al. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs. Clin Infect Dis. Published online February 3, 2020. doi:https:\/\/doi.org\/10.1093\/cid\/ciaa105","DOI":"10.1093\/cid\/ciaa105"},{"key":"6904_CR74","unstructured":"AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C. Accessed August 5, 2020. http:\/\/www.hcvguidelines.org"},{"issue":"1","key":"6904_CR75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M15-2634","volume":"165","author":"CL Bernard","year":"2016","unstructured":"Bernard CL, Brandeau ML, Humphreys K, et al. Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States. Ann Intern Med. 2016;165(1):10. doi:https:\/\/doi.org\/10.7326\/M15-2634","journal-title":"Ann Intern Med."},{"key":"6904_CR76","unstructured":"Centers for Disease Control and Prevention: US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 Update: a clinical practice guideline. Published online March 2018. Accessed November 17, 2019. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf."},{"issue":"2","key":"6904_CR77","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11606-016-3899-4","volume":"32","author":"A Silapaswan","year":"2017","unstructured":"Silapaswan A, Krakower D, Mayer KH. Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care. J Gen Intern Med. 2017;32(2):192-198. doi:https:\/\/doi.org\/10.1007\/s11606-016-3899-4","journal-title":"J Gen Intern Med."},{"key":"6904_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08897077.2019.1675118","volume":"23","author":"JL Taylor","year":"2019","unstructured":"Taylor JL, Walley AY, Bazzi AR. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs. Subst Abus. Published online October 23, 2019:1-3. doi:https:\/\/doi.org\/10.1080\/08897077.2019.1675118","journal-title":"Subst Abus"},{"key":"6904_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2019.02.030","volume":"200","author":"S Choi","year":"2019","unstructured":"Choi S, Biello KB, Bazzi AR, Drainoni M-L. Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: A focus on young adults. Drug Alcohol Depend. 2019;200:14-18. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.030","journal-title":"Drug Alcohol Depend."},{"key":"6904_CR80","doi-asserted-by":"publisher","unstructured":"Schechter-Perkins EM, Dwyer KH, Amin A, et al. Loop Drainage Is Noninferior to Traditional Incision and Drainage of Cutaneous Abscesses in the Emergency Department. Acad Emerg Med. Published online May 14, 2020. doi:https:\/\/doi.org\/10.1111\/acem.13981","DOI":"10.1111\/acem.13981"},{"issue":"4","key":"6904_CR81","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/QAI.0000000000001615","volume":"77","author":"MR Patel","year":"2018","unstructured":"Patel MR, Foote C, Duwve J, et al. Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2018;77(4):373-382. doi:https:\/\/doi.org\/10.1097\/QAI.0000000000001615","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes."},{"issue":"1","key":"6904_CR82","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/infdis\/jir196","volume":"204","author":"H Hagan","year":"2011","unstructured":"Hagan H, Pouget ER, Des Jarlais DC. A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs. J Infect Dis. 2011;204(1):74-83. doi:https:\/\/doi.org\/10.1093\/infdis\/jir196","journal-title":"J Infect Dis."},{"key":"6904_CR83","doi-asserted-by":"crossref","unstructured":"Wejnert C, Hess KL, Hall HI, et al. Vital Signs:: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs \u2014 United States. Morbidity and Mortality Weekly Report. 2016;65(47):1336-1342.","DOI":"10.15585\/mmwr.mm6547e1"},{"key":"6904_CR84","doi-asserted-by":"publisher","first-page":"102923","DOI":"10.1016\/j.drugpo.2020.102923","volume":"85","author":"A Whiteman","year":"2020","unstructured":"Whiteman A, Burnett J, Handanagic S, Wejnert C, Broz D, NHBS Study Group. Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015. Int J Drug Policy. 2020;85:102923. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2020.102923","journal-title":"Int J Drug Policy"},{"key":"6904_CR85","unstructured":"Resource Center | National Harm Reduction Coalition. Harm Reduction Coalition. Accessed September 17, 2020. https:\/\/harmreduction.org\/hrc2\/resource-center\/"},{"key":"6904_CR86","doi-asserted-by":"publisher","unstructured":"Motavalli D, Taylor JL, Childs E, et al. \u201cHealth Is on the Back Burner:\u201d Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs. J Gen Intern Med. Published online September 11, 2020. doi:https:\/\/doi.org\/10.1007\/s11606-020-06201-6","DOI":"10.1007\/s11606-020-06201-6"},{"issue":"5","key":"6904_CR87","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","volume":"38","author":"ST Syed","year":"2013","unstructured":"Syed ST, Gerber BS, Sharp LK. Traveling Towards Disease: Transportation Barriers to Health Care Access. J Community Health. 2013;38(5):976-993. doi:https:\/\/doi.org\/10.1007\/s10900-013-9681-1","journal-title":"J Community Health."},{"key":"6904_CR88","unstructured":"United States Department of Agriculture Economic Research Service. USDA ERS - Food Security and Nutrition Assistance. Accessed September 24, 2020. https:\/\/www.ers.usda.gov\/data-products\/ag-and-food-statistics-charting-the-essentials\/food-security-and-nutrition-assistance\/"},{"issue":"1","key":"6904_CR89","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10903-019-00946-x","volume":"22","author":"S Vais","year":"2020","unstructured":"Vais S, Siu J, Maru S, et al. Rides for Refugees: A Transportation Assistance Pilot for Women\u2019s Health. J Immigrant Minority Health. 2020;22(1):74-81. doi:https:\/\/doi.org\/10.1007\/s10903-019-00946-x","journal-title":"J Immigrant Minority Health."},{"key":"6904_CR90","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1097\/MLR.0000000000001029","volume":"57","author":"P de la Vega Buitron","year":"2019","unstructured":"de la Vega Buitron P, Losi S, Sprague Martinez L, et al. Implementing an EHR-based Screening and Referral System to Address Social Determinants of Health in Primary Care. Medical Care. 2019;57:S133. doi:https:\/\/doi.org\/10.1097\/MLR.0000000000001029","journal-title":"Medical Care"},{"key":"6904_CR91","unstructured":"Substance Abuse and Mental Health Services Administration. The Opioid Crisis and the Black\/African American Population: An Urgent Issue. Office of Behavioarl Health Equity, Substance Abuse and Mental Health Services Administration; 2020."},{"key":"6904_CR92","doi-asserted-by":"publisher","unstructured":"James K, Jordan A. The Opioid Crisis in Black Communities: The Journal of Law, Medicine & Ethics. Published online July 17, 2018. doi:https:\/\/doi.org\/10.1177\/1073110518782949","DOI":"10.1177\/1073110518782949"},{"key":"6904_CR93","unstructured":"Substance Abuse and Mental Health Services Administration. Substance Use Disorder Treatment for People with Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series, No. 42. SAMHSA Publication No. PEP20-02-01-004.; 2020. Accessed September 24, 2020. https:\/\/store.samhsa.gov\/sites\/default\/files\/SAMHSA_Digital_Download\/PEP20-02-01-004_Final_508.pdf"},{"issue":"4","key":"6904_CR94","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1176\/appi.ps.53.4.437","volume":"53","author":"G Gonzalez","year":"2002","unstructured":"Gonzalez G, Rosenheck RA. Outcomes and Service Use Among Homeless Persons With Serious Mental Illness and Substance Abuse. PS. 2002;53(4):437-446. doi:https:\/\/doi.org\/10.1176\/appi.ps.53.4.437","journal-title":"PS."},{"issue":"4","key":"6904_CR95","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1176\/appi.ps.52.4.469","volume":"52","author":"RE Drake","year":"2001","unstructured":"Drake RE, Essock SM, Shaner A, et al. Implementing Dual Diagnosis Services for Clients With Severe Mental Illness. PS. 2001;52(4):469-476. doi:https:\/\/doi.org\/10.1176\/appi.ps.52.4.469","journal-title":"PS."},{"issue":"1","key":"6904_CR96","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/15504263.2018.1518553","volume":"15","author":"V Karapareddy","year":"2019","unstructured":"Karapareddy V A Review of Integrated Care for Concurrent Disorders: Cost Effectiveness and Clinical Outcomes. Journal of Dual Diagnosis. 2019;15(1):56-66. doi:https:\/\/doi.org\/10.1080\/15504263.2018.1518553","journal-title":"Journal of Dual Diagnosis."},{"issue":"4","key":"6904_CR97","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMoa055255","volume":"355","author":"DA Fiellin","year":"2006","unstructured":"Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med. 2006;355(4):365-374. doi:https:\/\/doi.org\/10.1056\/NEJMoa055255","journal-title":"N Engl J Med."},{"key":"6904_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2016.01.003","volume":"63","author":"EL Bassuk","year":"2016","unstructured":"Bassuk EL, Hanson J, Greene RN, Richard M, Laudet A. Peer-Delivered Recovery Support Services for Addictions in the United States: A Systematic Review. J Subst Abuse Treat. 2016;63:1-9. doi:https:\/\/doi.org\/10.1016\/j.jsat.2016.01.003","journal-title":"J Subst Abuse Treat."},{"key":"6904_CR99","doi-asserted-by":"publisher","unstructured":"Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews. 2020;(3). doi:https:\/\/doi.org\/10.1002\/14651858.CD012880.pub2","DOI":"10.1002\/14651858.CD012880.pub2"},{"issue":"2","key":"6904_CR100","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","volume":"40","author":"SH Heil","year":"2011","unstructured":"Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011;40(2):199-202. doi:https:\/\/doi.org\/10.1016\/j.jsat.2010.08.011","journal-title":"J Subst Abuse Treat."},{"key":"6904_CR101","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","volume":"80","author":"M Terplan","year":"2015","unstructured":"Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med. 2015;80:23-31. doi:https:\/\/doi.org\/10.1016\/j.ypmed.2015.04.008","journal-title":"Prev Med."},{"issue":"9","key":"6904_CR102","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1111\/add.13840","volume":"112","author":"G Griffith","year":"2017","unstructured":"Griffith G, Kumaraswami T, Chrysanthopoulou SA, Mattocks KM, Clark RE. Prescription contraception use and adherence by women with substance use disorders. Addiction. 2017;112(9):1638-1646. doi:https:\/\/doi.org\/10.1111\/add.13840","journal-title":"Addiction."},{"issue":"8","key":"6904_CR103","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s10995-019-02754-z","volume":"23","author":"DB Stulberg","year":"2019","unstructured":"Stulberg DB, Dahlquist IH, Disterhoft J, Bello JK, Hunter MS. Increase in Contraceptive Counseling by Primary Care Clinicians After Implementation of One Key Question\u00ae at an Urban Community Health Center. Matern Child Health J. 2019;23(8):996-1002. doi:https:\/\/doi.org\/10.1007\/s10995-019-02754-z","journal-title":"Matern Child Health J."},{"key":"6904_CR104","doi-asserted-by":"publisher","unstructured":"Bryson A, Koyama A, Hassan A. Addressing long-acting reversible contraception access, bias, and coercion: supporting adolescent and young adult reproductive autonomy. Curr Opin Pediatr. Published online March 31, 2021. doi:https:\/\/doi.org\/10.1097\/MOP.0000000000001008","DOI":"10.1097\/MOP.0000000000001008"},{"issue":"2","key":"6904_CR105","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"IA Binswanger","year":"2007","unstructured":"Binswanger IA, Stern MF, Deyo RA, et al. Release from prison--a high risk of death for former inmates. N Engl J Med. 2007;356(2):157-165. doi:https:\/\/doi.org\/10.1056\/NEJMsa064115","journal-title":"N Engl J Med."},{"issue":"1-2","key":"6904_CR106","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","volume":"105","author":"A Nunn","year":"2009","unstructured":"Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105(1-2):83-88. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.06.015","journal-title":"Drug Alcohol Depend."},{"issue":"9991","key":"6904_CR107","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","volume":"386","author":"JD Rich","year":"2015","unstructured":"Rich JD, McKenzie M, Larney S, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015;386(9991):350-359. doi:https:\/\/doi.org\/10.1016\/S0140-6736(14)62338-2","journal-title":"Lancet."},{"key":"6904_CR108","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12954-015-0084-8","volume":"12","author":"H Zucker","year":"2015","unstructured":"Zucker H, Annucci AJ, Stancliff S, Catania H. Overdose prevention for prisoners in New York: a novel program and collaboration. Harm Reduct J. 2015;12:51. doi:https:\/\/doi.org\/10.1186\/s12954-015-0084-8","journal-title":"Harm Reduct J."},{"issue":"11","key":"6904_CR109","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","volume":"172","author":"SE Hadland","year":"2018","unstructured":"Hadland SE, Bagley SM, Rodean J, et al. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. JAMA Pediatr. 2018;172(11):1029-1037. doi:https:\/\/doi.org\/10.1001\/jamapediatrics.2018.2143","journal-title":"JAMA Pediatr."},{"issue":"3","key":"6904_CR110","doi-asserted-by":"publisher","first-page":"e20161893","DOI":"10.1542\/peds.2016-1893","volume":"138","author":"Committee on Substance Use And Prevention","year":"2016","unstructured":"Committee on Substance Use And Prevention. Medication-Assisted Treatment of Adolescents With Opioid Use Disorders. Pediatrics. 2016;138(3):e20161893. doi:https:\/\/doi.org\/10.1542\/peds.2016-1893","journal-title":"Pediatrics"},{"issue":"4","key":"6904_CR111","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jadohealth.2020.03.005","volume":"67","author":"RH Alinsky","year":"2020","unstructured":"Alinsky RH, Hadland SE, Matson PA, Cerda M, Saloner B. Adolescent-Serving Addiction Treatment Facilities in the United States and the Availability of Medications for Opioid Use Disorder. J Adolesc Health. 2020;67(4):542-549. doi:https:\/\/doi.org\/10.1016\/j.jadohealth.2020.03.005","journal-title":"J Adolesc Health."},{"key":"6904_CR112","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jsat.2018.07.011","volume":"93","author":"KA Feder","year":"2018","unstructured":"Feder KA, Mojtabai R, Musci RJ, Letourneau EJ. U.S. adults with opioid use disorder living with children: Treatment use and barriers to care. J Subst Abuse Treat. 2018;93:31-37. doi:https:\/\/doi.org\/10.1016\/j.jsat.2018.07.011","journal-title":"J Subst Abuse Treat."},{"key":"6904_CR113","doi-asserted-by":"publisher","unstructured":"Link HM, Jones H, Miller L, Kaltenbach K, Seligman N. Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis. American Journal of Obstetrics & Gynecology MFM. 2020;2(3). doi:https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100179","DOI":"10.1016\/j.ajogmf.2020.100179"},{"key":"6904_CR114","unstructured":"Pregnancy and Substance Use: A Harm Reduction Toolkit. Harm Reduction Coalition. Accessed December 4, 2020. https:\/\/harmreduction.org\/issues\/pregnancy-and-substance-use-a-harm-reduction-toolkit\/"},{"key":"6904_CR115","unstructured":"Substance Abuse and Mental Health Services Administration. Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants. Substance Abuse and Mental Health Services Administration; 2018. Accessed December 4, 2020. https:\/\/store.samhsa.gov\/product\/Clinical-Guidance-for-Treating-Pregnant-and-Parenting-Women-With-Opioid-Use-Disorder-and-Their-Infants\/SMA18-5054"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-021-06904-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:19:38Z","timestamp":1744175978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-021-06904-4"}},"subtitle":["Harm Reduction in Outpatient Addiction Treatment"],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":115,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6904"],"URL":"https:\/\/doi.org\/10.1007\/s11606-021-06904-4","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"11 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}